Description
A Phase IIR/III Trial of Standard of Care Therapy With or Without Stereotactic Body Radiotherapy (SBRT) and/or Surgical Ablation for Newly Oligometastatic Breast Cancer
This trial is available at multiple Sutter Locations. Please contact one of the following about Study NRG BR002
San Francisco: ClinicalResearch@sutterhealth.org
Palo Alto/Santa Cruz: Tanya Pozniansky pozniat@sutterhealth.org
East Bay: James Nasman NasmanJ@sutterhealth.org and Vivian Leong, RN Leongv@sutterhealth.org
Sacramento: Isabel Rodrigues-Fong Rodrigi@sutterhealth.org and Kirsten Babski babskik@sutterhealth.org
Modesto: Delia Massone MassonD@sutterhealth.org and Adrienne Palos PalosA@sutterhealth.org
Solano-Vallejo Cancer Center: Stephanie Gonzales gonzals@sutterhealth.org
Recruitment is currently on hold for data analysis
View study details on ClinicalTrials.govPrincipal Investigator
Oleg I. Krijanovski, M.D., Ph.D.
Recruitment Status
Active, Not Recruiting
Start Date
February 01, 2019
Related Studies
Breast Cancer Chemoprevention in Primary Care at Geisinger
Investigators: Xiaowei (Sherry) Yan, PhD, MS, External PI, Principal Investigator
Impact of COVID-19 on Cancer Care Management
Investigators: Monique de Bruin, M.D., MPH, Su-Ying Liang, Ph.D.
POLARIS Palbociclib in Real World Practice
Investigators: Nitin Rohatgi, MD, Vijay Suhag, M.D., Kristin N. Arreola, M.D., Brian K. Kim, M.D, Rajeswari Chellappah, M.D., Sivakumar Reddy, M.D., Kristie A. Bobolis, M.D.